The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Statins: mechanism of action and effects
Open accessAbstract
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the Statin class of drugs inhibit 3-hydroxy-3-methylglutaryl (HMG) CoA reductase (HMGCR), the rate-limiting enzyme of de novo cholesterol synthesis5”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Statins (3-Hydroxy-3-methylglutaryl CoA reductase inhibitors) inhibit the endogenous synthesis of cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway.(14)”
From Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis (2025) · cites this paper as [14]
In the citing paper
“Statins are competitive inhibitors of HMG-CoA reductase, which catalyses the conversion of HMG-CoA to mevalonate, a rate-limiting step in the isoprenoid biosynthetic pathway, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi [10] .”
From Statins as antifungal agents (2011) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Research works printed but not linked: 2
- Voet D., 1995, Biochemistry, 315
- StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).
Cited by
Sorted by citations
Items 701–800 of 910
Breaking barriers: Innovative therapies for managing homozygous familial hypercholesterolemia
Huang, S.-J., Huang, P. H., Song, N.-N., Jia, X.-H., Gao, H., Lu, Z., & Wen, X. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.105003 · Cited by 1
Venkatraman, R., Narayanan, V. H. B., Nowakowski, S., Nellinger, S., Kluger, P. J., Kopka, B., Brzeziński, M., Sankar, A., & Durai, R. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-31548-3 · Cited by 1
Castaldi, M. A., & Gragnano, F. M. (2026) · The Linacre Quarterly · doi:10.1177/00243639261421887 · Cited by 1
Khan, S., Lyu, Y., Mamillapalle, V., Jeon, M. S., Pourali, G., Luo, C., Luo, J. R., & Toriola, A. T. (2026) · Metabolomics · doi:10.1007/s11306-026-02467-9 · Cited by 1
Insights on cholesterol nutrition: shift to a new paradigm for better cardiovascular health
Bishwajit, G., Kpoghomou, M.-A., Shamsitdinov, H., Mondal, A., & Sarker, S. (2013) · Cited by 1
Li, Y., Ding, J., Ge, B.-X., & Miao, C. (2013) · Open Medicine · doi:10.2478/s11536-013-0245-7 · Cited by 1
Review Biosynthesis of isoprenoids via the non-mevalonate pathway
Eisenreich, W., Bacher, A., & Rohdich, F. (2004) · Cited by 1
Pengaruh Pasta Tomat Terhadap Kolesterol Darah Mencit
Nugraheni, F. S. A., Jailani, J., & Purwati, S. (2019) · Bioeksperimen Jurnal Penelitian Biologi · doi:10.23917/bioeksperimen.v5i2.9244 · Cited by 1
Ameliorative Effects and Cellular Aspects of Phytoconstituents in Atherosclerosis
Alamgeer, Asif, H., Sandhu, M. Z. A., Aziz, M., Irfan, H. M., Moreno, K. G. T., & Gasparotto, A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200214161139 · Cited by 1
Intradiscal Therapeutics for Degenerative Disc Disease
Mowbray, J., Shen, B., & Diwan, A. D. (2020) · Springer eBooks · doi:10.1007/978-3-319-33037-2_92-1 · Cited by 1
Effect of Atorvastatin on Bone biochemical markers in dyslipidemic patients, Basra, Iraq
Shari, F. H. (2016) · Iraqi National Journal of Nursing Specialties · doi:10.58897/injns.v29i1.242 · Cited by 1
Lee, J., Kim, M., Lee, J., & Chang, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226756 · Cited by 2
VENUNGOPAL, P., BALAKRISHNAN, K., Sriram, D. K., & George, M. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i12.46054 · Cited by 1
Statins and COVID-19 (Mechanism of Action, Effect on Prognosis)
Lewek, J., Surma, S., & Banach, M. (2022) · Contemporary cardiology · doi:10.1007/978-3-031-15478-2_17 · Cited by 1
PRANDOTA, J. (2023) · Journal of Clinical Medicine Current Research · doi:10.53043/2832-7551.jcmcr.3.007 · Cited by 2
Huang, N. J., Xing, Q., Li, W., Yan, Q., Liu, R., Liu, X., & Liu, Z. (2023) · Medicine · doi:10.1097/md.0000000000034362 · Cited by 1
Divergent Approaches Toward Drug Discovery and Development
Koul, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-1284-1_34 · Cited by 1
Lipid-lowering therapy for hypertriglyceridemia-induced acute pancreatitis: Recent advances
Chen, H., Su, D.-S., Li, H., Guo, X., & Qi, X. (2023) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v31.i21.882 · Cited by 1
John, A. M., Baby, A., Rahim, A. J., Baby, B., & Babu, E. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00696 · Cited by 1
Fitzgerald, M., & Hall, H. (2024) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2024.106848 · Cited by 1
Sayed, A., Swanson, J., Kip, K., Jesrani, E. K., Reis, S. E., & Saeed, A. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.08.003 · Cited by 1
Raja, K. D., Kumari, A. S., & Rani, A. P. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/43619 · Cited by 1
A Case of Statin-Induced Necrotizing Autoimmune Myopathy
Desai, I., Modi, S. K., & Subhan, A. (2024) · Cureus · doi:10.7759/cureus.70852 · Cited by 1
When herpes zoster is not herpes: A case of statin-induced myopathy complicated by drug allergies
Kareem, H. K., Ashraf, M. F., Shehryar, M., Fayyaz, H., & Patil, S. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02164 · Cited by 1
Effects of atorvastatin and its photoproducts on three trophic levels of the aquatic food web
Poncarová, M., Šorf, M., Poštulková, E., Klementová, Š., Hájek, J., Fojtíková, P., Kahoun, D., Hrouzek, P., Medková, D., & Petráňová, P. (2025) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-025-06551-w · Cited by 1
Liles, M. R., Guzman, D. S.-M., Knych, H. K. D., & Beaufrère, H. (2025) · American Journal of Veterinary Research · doi:10.2460/ajvr.25.04.0117 · Cited by 1
Modeling and Simulation in the Development of Cardiovascular Agents
Mould, D. R., Frame, B. C., & Taylor, T. (2010) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4419-7415-0_10 · Cited by 1
Mechanisms of Action of Drugs for Treating Endothelial Dysfunction in Diabetes Mellitus
Nizami, H. L., & Banerjee, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_22 · Cited by 1
Rao, K. N. S. V. C., Vankayala, A., Sayana, S. B., & Raju, D. S. S. K. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20191519 · Cited by 1
Antiasthmatic effect of atorvastatin via modulation of macrophage activation
Mo, Y., Bae, B., Kim, Y., Kang, H., Lee, H. S., Cho, S., & Kang, H. (2021) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2021.9.1.27 · Cited by 1
A Study on the Analysis of Personal Gut Microbiomes
Vasieva, O., Sorokin, A., Murzabaev, M., Babiak, P., & Goryanin, I. (2019) · Journal of Computer Science & Systems Biology · Cited by 1
Quimioprevenção e câncer no contexto brasileiro: Da higidez ao diagnóstico
Baptistella, M. M., de Oliveira, C. S., Assunção, R. R. S., & de Oliveira, P. F. (2021) · Research Society and Development · doi:10.33448/rsd-v10i8.17448 · Cited by 1
Common systemic medications that every optometrist should know
Williams, R. M., & Hui, A. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.1945409 · Cited by 1
الدليمي, إ. خ. ح., شاكر, أ. ه., & ياسين, ف. خ. (2021) · iraq journal of market research and consumer protection · doi:10.28936/jmracpc13.2.2021.(7 · Cited by 1
Setyawati, I. (2022) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v6i5.502 · Cited by 1
Hyperlipidemia and rheumatoid arthritis
Venetsanopoulou, A. I., Voulgari, P. V., & Drosos, A. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00003-1 · Cited by 1
Drug-Induced Pruritus Without Primary Rash
Golpanian, R. S., Yosipovitch, G., & Dodiuk‐Gad, R. P. (2022) · Updates in clinical dermatology · doi:10.1007/978-3-031-09388-3_18 · Cited by 1
Sierra, V., Moreno-Vargas, E. A., Escandón-Castillo, S., Rincón-García, D., Silva-Duran, A., & Bayona, H. (2023) · Acta neurológica colombiana · doi:10.22379/24224022433 · Cited by 1
Yang, M., & Huang, Q. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.48.007632 · Cited by 1
Dyslipidemia in Metabolic Syndrome
Toh, S.-A. E. S., & Lee, M. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_58 · Cited by 1
SIMVASTATIN INDUCES MITOCHONDRIAL LOSS AND PTEN-MEDIATED AUTOPHAGY
Lee, P. S. (2012) · California State University ScholarWorks (system-wide DSpace) · Cited by 1
Suh, H. S. (2015) · University of Southern California Digital Library · doi:10.25549/usctheses-m2519 · Cited by 1
Al-Habsi, A. A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-6632 · Cited by 1
(2006) · Springer eBooks · doi:10.1007/3-540-29832-0_772 · Cited by 1
Liu, Y., Liu, P., Song, Y., Li, S., Shi, Y., Quan, K., Yu, G., Li, P., An, Q., & Zhu, W. P. (2021) · Research Square · doi:10.21203/rs.3.rs-255688/v1 · Cited by 1
Jabbari, A., Argani, H., Ghorbanihaghjo, A., & Mahdavi, R. (2015) · Cited by 1
Grau, J. B. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.09.029 · Cited by 1
Tanner, L., Bergwik, J., Bhongir, R. K. V., & Egesten, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.01.470755 · Cited by 1
Shah, A., Sharma, K. H., Rawal, S., Sisodia, R., Bhatt, P. K., Christian, C., & Konat, A. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.916695 · Cited by 1
Ali, S., Ali, U., & Jan, M. I. (2023) · Preprints.org · doi:10.20944/preprints202312.1621.v1 · Cited by 1
Ali, S., Ali, U., & Jan, M. I. (2024) · Preprints.org · doi:10.20944/preprints202312.1621.v2 · Cited by 1
Synthesis of a Cationic Inorganic Layered Material for Trapping Anionic Pharmaceutical Pollutants
Sergo, K. M. (2013) · eScholarship (California Digital Library) · Cited by 1
Mentch, M. L. (2013) · OpenCommons - UConn (University of Connecticut)
Hansson, M. E. A. (2007) · Figshare
Statins in the Reduction of Cardiovascular Events
Sachdeva, R., Hughes, B. R., & Mehta, J. L. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse450
Side-chain oxidized oxysterols as metabolic regulators in liver and brain
Ali, Z. (2014) · Figshare
Role of Neural Stem and Progenitor Cells in the Adaptation of the Brain to Injury
Hong, S. J., Yu, T., & Kernie, S. G. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4899-7399-3_4
Cholesterol Binding Activity of ApoAI Mimetic Peptide L4F
Onkar, S. S. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Quality Enhancement by Inclusion Complex Formation of Simvastatin Tablets
RÉDAI, E. M., Sipos, E., Zs, P., Tőkés, B., & Székely, P. (2013) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2013-0052
SAFETY EVALUATION OF STATIN IN YOGYAKARTA, INDONESIA
Perwitasari, D. A., Anni, A., Labado, R. O., & Udu, W. S. A. (2009) · Selamat Datang di Repository UAD (Universitas Ahmad Dahlan)
Role of high-density lipoprotein cholesterol in renovascular disease treatment.
Ziaie, S. (2015) · Iranian Journal of Kidney Diseases
PHENOTYPICAL CHARACTERIZATION OF BOTRYTIS CINEREA PERS. STRAINS ISOLATED FROM ORNAMENTAL PLANTS
MICLEA, R. V., & Puia, C. (2011)
Varnier, N. A., Pettit, F., Rees, D. M., Thou, S., Brown, M. A., & Henry, A. (2015) · Obstetric Medicine · doi:10.1177/1753495x15593451
Nunes, N. M. (2010) · Americanae (AECID Library)
Simvastatin Encapsulation in Alginate-Based Microspheres
Ava, P. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-863
The Role of Coenzyme Q10 in Statin Treated Zebrafish (Danio rerio)
Pasha, R. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3864
Abel, C. (2007) · Max Planck Institute for Plasma Physics
Georgiou, A. (2015) · Spiral (Imperial College London) · doi:10.25560/31680
Clinical Treatment of Vascular Diseases
Inglez, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46059-8_19
Side-chain oxidized oxysterols as metabolic regulators in vivo
Ali, Z. (2017) · Figshare
Bingi, P. K. (2017) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.17660
Sattar, J. (2015) · TSpace (University of Toronto)
The Clinical Utility of Genetic Risk Scores Following Myocardial Infarction
Northcott, H. (2016) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17061737
Ferreira, D. B., de Queiróz, J. H., Pizziolo, V. R., de Oliveira, T. T., & da Matta, S. L. P. (2018) · Revista Interdisciplinar de Estudos Experimentais - Animais e Humanos Interdisciplinary Journal of Experimental Studies · doi:10.34019/2177-3459.2017.v9.24037
Statins and Cholesterol: A Perspective Revisited
Raina, V. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i4.203
Role of Cholesterol in Heart Disease
Vučić, V., & Masnikosa, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.21339-5
PCB-associated steatohepatitis and the role of nuclear receptors.
Clair, H. B. (2017) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2867
Correlation between Statin use and Intracranial Haemorrhage
Kulkarni, S. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i5.141
Evaluation of the Effect of Biotin in Dyslipidemia
Asvini, N. (2015)
Modulating Aged Macrophages and Osteoprogenitors with a Calcium Phosphate Drug Delivery System
Alhamdi, J. R. (2018) · OpenCommons at University of Connecticut (University of Connecticut)
Homozygous familial hypercholesterolemia with valvulopathy
Manappallil, R., Nambiar, A., Kumar, V. P., & Sarpamale, A. (2019) · Journal of Clinical and Preventive Cardiology · doi:10.4103/jcpc.jcpc_26_18
Antisense Technology: Liver Targeting and Beyond for Drug Discovery
Geary, R. S., Baker, B. F., & Monia, B. P. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00062
Smith, L. E., & Billings, F. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00223-5
Role of Ancient Ubiquitous Protein 1 in Hepatic ApoB Degradation and VLDL production
Zamani, M. (2016) · TSpace (University of Toronto)
Mohammed, S. S., & Shredah, M. (2017) · Tanta Dental Journal · doi:10.4103/tdj.tdj_58_16
Pharmacoepigenetics of Statins
Zambrano, T., Saavedra, K., & Salazar, L. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00031-0
Dewi, Y. K. (2019) · Pharmaceutical Journal of Indonesia
Cárdenas, A. M., Fernández, A., V, Gutiérrez, M. P. P., & Navarro, G. (2019) · Ustasalud · doi:10.15332/us.v17i0.2186
Vanajakshamma, V., Kasala, L., & Chanda, N. (2019) · Indian Journal of Cardiovascular Disease in Women · doi:10.1055/s-0039-1697076
On secondary prevention after acute coronary syndrome : -what, when, and who
Huber, D. (2019) · DiVA at Umeå University (Umeå University)
A study of the global effects of Apolipoprotein E using lipidomics
Hawksworth, J. I. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Selective LXR agonist, DMHCA, corrects the retina-bone marrow axis in type 2 diabetesPreprint
Vieira, C. P., Fortmann, S. D., Hossain, M., Longhini, A. L., Hammer, S. S., Asare-Bediako, B., Crossman, D., Sielski, M. S., Adu-Agyeiwaah, Y., Dupont, M., et al. (2020) · bioRxiv · doi:10.1101/2020.02.11.942292
EFEK PEMBERIAN MADU TRIGONA TERHADAP KADAR ALBUMIN TIKUS PUTIH YANG DIINDUKSI ATORVASTATIN
Salampe, M., & Mamada, S. S. (2020) · Media Farmasi · doi:10.32382/mf.v16i1.1376
Samy, M., Fouda, A. M., Daba, M.-H., & Yassin, A.-R. (2016) · Mansoura Medical Journal · doi:10.21608/mjmu.2016.111227
Dyslipidemia in the Pediatric Population
Sunil, B., & Ashraf, A. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-52215-5_57
Metadata
- Authors
- Stancu, C., & Sima, A.
- Affiliations
- Romanian Academy (RO)
- Corresponding author
- Sima, Anca
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 4
- Pages
- 378-387
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC6740083
- OpenAlex
- W2006572302
- Cited by
- 911
- References
- 42
- Citations by year
- 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
- MeSH terms
- Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review